Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001564590-21-050016
Filing Date
2021-10-04
Accepted
2021-10-04 16:02:03
Documents
8
Effectiveness Date
2021-10-04

Document Format Files

Seq Description Document Type Size
1 S-3ASR xene-s3asr.htm S-3ASR 422545
2 EX-5.1 xene-ex51_6.htm EX-5.1 69449
3 EX-23.1 xene-ex231_7.htm EX-23.1 19505
4 GRAPHIC guwwknhhemjp000001.jpg GRAPHIC 14552
5 GRAPHIC gc34hufxe2ah000001.jpg GRAPHIC 7563
6 GRAPHIC guqmocftmvt0000001.jpg GRAPHIC 2469
7 GRAPHIC gc34hufxe2ah000002.jpg GRAPHIC 7563
8 GRAPHIC guwwknhhemjp000002.jpg GRAPHIC 28227
  Complete submission text file 0001564590-21-050016.txt   596414
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-260010 | Film No.: 211302643
SIC: 2834 Pharmaceutical Preparations